Evgen releases data from SFX-01 trial
The study is specifically analysing the company’s new enteric coated tablet formation of the drug
Read More
Tag: SFX-01
Evgen completes three cohorts for SFX-01
New enteric-coated tablet formulation will now replace the previous prototype capsule
Read More
Evgen to investigate new SFX-01 tablet formulation
The therapy has the potential to treat neurological and oncological conditions
Read More
Regulatory approval received for Evgen’s SFX-01 study
New formulation may be suitable for large-scale trials and commercial supply in the future
Read More
Evgen’s SFX-01 selected for COVID-19 trial
The company is participating in LifeArc’s funding initiative for COVID-19 clinical trials
Read More
- SolasCure trial shows faster healing with Aurase Wound Gel
- Gilead data show investigational HIV combination maintains viral suppression
- Verdiva Bio completes enrolment for phase 2b study of oral GLP‑1 candidate VRB‑101
- MHRA approves imlunestrant tosylate as new breast cancer treatment
- ACD440 granted orphan drug status in the EU
